Members of the N-methyl-D-aspartate (NMDA) class of glutamate receptors (NMDARs) are critical for development, synaptic transmission, learning and memory; they are targets of pathological disorders in the central nervous system. NMDARs are phosphorylated by both serine͞threonine and tyrosine kinases. Here, we demonstrate that cyclin dependent kinase-5 (Cdk5) associates with and phosphorylates NR2A subunits at Ser-1232 in vitro and in intact cells. Moreover, we show that roscovitine, a selective Cdk5 inhibitor, blocks both long-term potentiation induction and NMDAevoked currents in rat CA1 hippocampal neurons. These results suggest that Cdk5 plays a key role in synaptic transmission and plasticity through its up-regulation of NMDARs.
T
he N-methyl-D-aspartate (NMDA) class of glutamate receptors (NMDAR) are essential for learning, memory, and development in the central nervous system (1) (2) (3) (4) (5) . NMDARs are multimeric complexes formed from both NMDA receptor subunit (NR1) and modulatory NR2 subunits (6) (7) (8) (9) . A single gene encodes the NR1 subunit. Eight possible alternative RNA-splice variants provide molecular diversity of NMDARs (10) . NR2A-NR2D are encoded by four separate genes (11, 12) . NMDARs consist of NR1͞NR2 heteromeric complexes (13) (14) (15) . The activation of NMDARs and the influx of Ca 2ϩ into the postsynaptic cells through the receptor are important for the induction of long-term synaptic plasticity, including long-term potentiation (LTP; ref. 16 ).
NMDA-channel activity is dynamically modulated in both intracellular and extracellular sites (3) . Phosphorylation sites have been identified on the NR1, NR2A, and NR2B subunits, but not on the NR2C-NR2D subunits. Protein kinase C phosphorylates Ser-890 and Ser-896, and protein kinase A phosphorylates Ser-897 within the C1 exon of the NR1 subunit (17) (18) (19) . Calcium͞calmodulin protein kinase II mediates phosphorylation of NR2B, but not NR2A (20) . More recently, phosphorylation at tyrosine residues of NR2A and NR2B has been described as an important determinant for NMDAR functions (19) (20) . In particular, Fyn, a member of the Src family of nonreceptor protein tyrosine kinases, was shown to phosphorylate the NR2A (7, (21) (22) (23) . However, no information is available concerning which kinases phosphorylate NR2A at serine͞threonine sites. Cyclindependent kinase-5 (Cdk5) is a serine͞threonine kinase that is activated by neuron-specific p35 and p39 proteins (24) (25) (26) (27) . It exists as a large, multimeric complex associated with cytoskeletal proteins in the neurons. Cdk5 has been shown to phosphorylate a wide variety of proteins, all of which have serine͞threonine sites in (K͞RT͞SPXK)-type motifs (28, 29) . A number of synaptic proteins have been identified as Cdk5 substrates (30) (31) (32) . Cdk5 and p35, predominantly expressed in postmitotic neurons, play essential roles in neuronal migration, neurite outgrowth, and laminar configuration of the cerebral cortex (25, 27, 33) . Cdk5 in association with p25, a truncated form of p35, hyperphosphorylates the microtubule-associated protein tau. This hyperphosphorylation is thought to disrupt the neuronal cytoskeleton and ultimately contributes to neurodegeneration in Alzheimer's disease (34) .
Because of its virtue of phosphorylating so many diverse substrates, Cdk5 has been proposed to participate in synaptic transmission and plasticity by phosphorylating NMDAR subunits. Here, we show that Cdk5 directly phosphorylates NR2A on Ser-1232 both in vitro and in intact cells. This phosphorylation can be inhibited by roscovitine, a Cdk5-specific inhibitor. Moreover, we show that inhibition of the Cdk5 activity prevents induction of LTP in CA1 pyramidal cells of rats. These findings indicate that, through phosphorylation of the NR2A subunit, Cdk5 may play a key role in synaptic transmission.
Materials and Methods
Constructs. The 920-bp wild-type and mutant NR2A fragments (C-terminal domain from amino acid 1159 to 1464) were generated by reverse transcription-PCR from rat brain RNA by using primers corresponding to the C-region of NR2A. Wildtype Cdk5, inactive mutant Cdk5 (K33T), and p35 in pcDNA3 were gifts from L.-H. Tsai (Harvard Medical School, Boston, MA). HA-tagged wild-type and mutant (S1232A) NR2A in pcDNA3, recombinant His-tagged wild-type and mutant (S1232A) NR2A C-terminal domain were generated by standard cloning methods. The putative phosphorylation site in NR2A was mutated by using the Quick-Change site-directed mutagenesis kit (Stratagene) according to the manufacturer's instructions. The mutation was verified by DNA sequencing.
Cell Culture. The hippocampal region from E 16 Cdk5 wild-type (Cdk5 ϩ/ϩ ) and knockout mice (Cdk5 Ϫ/Ϫ ) embryos were dissected and minced well with scissors. The dissociated cells were collected by centrifugation and resuspended in a serum-free neurobasal medium supplemented with B-27 supplement and 0.5 mM L-glutamine (Life Technologies, Rockville, MD). Cells (25 ϫ 10 3 ) were plated in 35-mm plastic dishes precoated with laminin (10 g͞ml; Life Technologies) and allowed to grow for 5 days. HEK293T cells were cultured in DMEM with 10% (vol͞vol) FCS.
In Situ Hybridization. Digoxigenin-labeled Cdk5 riboprobes were used for in situ hybridization. The digoxigenin probes were potential ranging from Ϫ71 mV to Ϫ78 mV. The holding potential for voltage-clamp recordings was Ϫ75 mV.
Results
The consensus phosphorylation sequence of Cdk5 is XR͞KS͞ TPXK͞R. One such putative Cdk5 phosphorylation motif (RSPFK) is present in the NR2A subunit (Ser-1232; see Fig. 2A ) but not in other NR2 subunits (NR2B-D). To find out whether NR2A is an in vivo Cdk5 substrate, we first investigated the distribution of Cdk5 in rat brain to see whether it colocalized with NR2A. The highest levels of Cdk5 were detected in the cerebral cortex and hippocampal ( Fig. 1 A-D) regions expressing high levels of NR2A (35, 36) . Cdk5 is detected in both pre-and postsynaptic sites in the cerebral cortex by immunogold labeling (Fig. 1E) . These ultrastructural studies add support to light microscopic and biochemical findings (described later), indicating a presence of Cdk5 in synaptic regions. To determine whether Cdk5 is present in the PSD fraction of the brain, we followed the association of Cdk5 protein during biochemical purification of the PSD. By Western blot analysis, we observed that Cdk5 protein is in whole-cell extracts of the cerebral cortex, in a synaptosomal fraction, and in purified PSD (Fig. 1F) . We also asked whether Cdk5 is associated with NR2A by coimmunoprecipitation. Cell extracts from the cerebral cortex were solubilized with 1% deoxycholate and IP with Cdk5, NR2A, PSD-95 (NR2A is known to associate with PSD-95; ref. 37), or control (preimmune IgG) antibodies. Cdk5, NR2A, and PSD-95 were all co-IP by antibodies specific for these proteins, but not by control antibody (preimmune IgG; Fig. 1G ). Because antibodies to Cdk5 brought down a significant amount of both PSD-95 and NR2A, a ternary complex containing Cdk5͞NR2A͞ PSD-95 is likely to exist. To examine whether Cdk5 also is colocalized specifically with NR2A, we performed doublelabeled immunofluorescence staining of cultured hippocampal neurons. Cdk5 colocalizes with NR2A in hippocampal neurons ( Fig. 1 H-J) .
To test whether NR2A is an in vitro substrate for Cdk5 phosphorylation, HEK293T cells were cotransfected with wildtype or the kinase-inactive mutant Cdk5 (K33T; ref. 38) , and the status of phosphorylation of the recombinant NR2A was assessed by immunoprecipitation of the wild-type and mutant (K33T)-Cdk5. Cells transfected with active Cdk5͞p35 phosphorylated both histone H1 and recombinant NR2A (Fig. 2B) , whereas the immunoprecipitate from cells transfected with mutant (K33T) or treated with roscovitine, a Cdk5-specific inhibitor (39), did not phosphorylate either substrate (Fig. 2B) . The expression levels of the wild type and the mutant Cdk5 K33T were the same in these cells (data not shown).
Because Ser-1232 of NR2A is the ideal consensus sequence (RSPFK) of Cdk5 (Fig. 2 A) , Ser-1232 was mutated to Ala (S1232A). The ability of Cdk5 to phosphorylate wild-type and mutant HA-NR2A (C-region, S1232A) was examined by an in vitro kinase assay with GST-Cdk5͞GST-p35. Cdk5 phosphorylated wild-type NR2A but not the mutant S1232A (Fig. 2C) , which supports Ser-1232 as the phosphorylation site of Cdk5.
To establish further that Cdk5 activity is necessary for phosphorylation of NR2A, we first compared expression of NR2A in cultured neurons from Cdk5 knockout (Cdk5 Ϫ/Ϫ ) and wild-type (Cdk5 ϩ/ϩ ) mice by reverse transcription-PCR and Western blot analysis. Cdk5 Ϫ/Ϫ and wild-type mice exhibited similar levels of NR2A mRNA and protein expression (Fig. 3 A and B) . We then compared the phosphorylation state of NR2A by using cultured hippocampal neurons from Cdk5 Ϫ/Ϫ and wild-type mice. Cells were metabolically labeled with [ 32 P]orthophosphate. The levels of phosphorylated NR2A were measured by immunoprecipitation with anti-NR2A antibody and autoradiography, and its phosphorylation state and protein levels were quantified. Neurons from wild-type mice exhibited greater than 2-fold phosphorylation of NR2A, compared with neurons from Cdk5 Ϫ/Ϫ mice (Fig. 3C) . To demonstrate further that Ser-1232 in NR2A is phosphorylated by Cdk5, the HEK293T cells were cotransfected with wild-type HA-NR2A (C region, S1232), or mutant HA-NR2A (S1232A) were cotransfected with wild-type Cdk5͞ p35 and then metabolically labeled with [ 32 P]orthophosphate. The levels of phosphorylated HA-NR2A were measured by immunoprecipitation with anti-HA-tagged antibody, and its phosphorylation state and protein levels were quantified. Coexpression of wild-type HA-NR2A and Cdk5͞p35 resulted in enhancement of HA-NR2A phosphorylation compared with coexpression of mutant HA-NR2A and Cdk5͞p35 (Fig. 3D) .
LTP is an activity-dependent strengthening of synaptic efficacy that is considered to be a basic mode of learning and memory (40) . In area CA1 of the hippocampus, either one or multiple trains of high-frequency stimulation are used to induce the most commonly studied forms of LTP (41) . This form requires postsynaptic Ca 2ϩ influx and depends on NMDAR activation (42) (43) (44) . Therefore, we investigated whether Cdk5 is involved in NMDAR-dependent LTP induction. Stimulation of the Schaffer collateral inputs to CA1 neurons evoked EPSP. It is well established that the LTP at these synapses depends on the activation of the postsynaptic NMDARs (10, 22) . To determine whether Cdk5 affects LTP induction, we made use of roscovitine, a specific inhibitor of Cdk5 (39) , to examine its effects on the rat hippocampal CA1 long-term synaptic potentiation. Tetanic trains induced EPSPs and LTP in the absence of the roscovitine. For instance, 40 min after tetanization, the EPSPs increased (156.9 Ϯ 7.2% of baseline EPSP; n ϭ 6) significantly (P Ͻ 0.05) from their control values (Fig. 4 A and C) . In contrast, in the presence of extracellular roscovitine (5 M), tetanic stimulation induced only a brief posttetanic potentiation of EPSPs (Fig. 4 B and C) . LTP, however, was not induced. Thus, 40 min after the tetanization (100.9 Ϯ 5.2% of baseline ESPS; n ϭ 6; Fig. 4C ), the EPSPs did not differ significantly (P Ͼ 0.05, paired t test) from the value before the tetanization in the presence of roscovitine (5 M).
The blockade of LTP by roscovitine did not seem to involve an action at non-NMDARs. The EPSPs were largely eliminated (98.5 Ϯ 4.2% of baseline value; n ϭ 7; P Ͻ 0.05) by 100 M extracellular 6-cyano-7-nitroquinoxaline-2, 3-dione, a selective non-NMDAR antagonist (data not shown). Roscovitine (5 M), when applied alone, had no detectable effects on the EPSPs (n ϭ 6) but significantly reduced the inward current induced by local application of NMDA (110.5 Ϯ 6.8 pA to 60.3 Ϯ 4.2 pA; n ϭ 5; P Ͻ 0.05) (Fig. 4 D and E) . These responses were blocked by 50 M dextrorotatory and levorotatory (DL)-2-amino-5-phosphovaleric acid, a selective NMDAR antagonist (data not shown).
Discussion
The evidence presented here identifies Cdk5 as a potential regulator of NMDA receptor, NR2A. Cdk5 phosphorylation of NR2A at Ser-1232 affects NMDAR activity, as indicated by the regulation of NMDA-induced LTP in CA1 neurons. These effects were inhibited by roscovitine, a specific Cdk5 inhibitor. These results indicate that the observed changes of NMDAR activity in neurons are caused by, at least in part, NR2A-subunit phosphorylation by Cdk5, which, in turn, up-regulates NMDAR activity.
Cdk5 Ϫ/Ϫ mice exhibit a unique phenotype with perinatal mortality and associated disruption of cerebral cortical layering, cerebellar foliation, and degeneration of neurons in the brainstem and the spinal cord (24, 45) . Transgenic knockout mice that express Cdk5 only in the p35-expressing brain regions in endogenous Cdk5-null mice reversed the phenotype observed in Cdk5-null mice (46) . These Cdk5 transgenic animals were viable and fertile. These studies indicate that neuronal Cdk5 activity is critical for embryonic development and survival. The Cdk5͞p35 complex recently has been shown to phosphorylate Munc-18 and amphiphysin, which in turn affect neuronal exocytosis and neurite outgrowth (30, 32, (47) (48) , and dopamine and cAMP-regulated phosphoprotein of Mr 32,000 (DARPP-32), a bifunctional signal-transduction molecule that controls the activity of protein phosphatase 1 and protein kinase A through the phosphorylation of Thr-75 by Cdk5. Phosphorylation of DARPP-32 by Cdk5͞p35 has been implicated in the regulation of dopamine signaling (49) . In a recent study, Cdk5 was shown to phosphorylate the regulatory subunit of cGMP-phosphodiesterase in a GTPdependent manner in photoreceptor outer segment membrane (50) . These studies indicate that Cdk5 plays an important role in synaptic transmission.
Adult mice lacking NR2A show defective LTP and impaired spatial memory (51) , indicating that NR2A is an important modulator during LTP. Several reports have related biochemical events underlying the induction of LTP in hippocampal CA1 neurons with the signaling cascades initiated by Ca 2ϩ inf lux through NMDARs (40, 41, 52 ). Our results demonstrate that roscovitine, a specific Cdk5 inhibitor, reduced LTP induction and significantly inhibited the inward current induced by the local application of NMDA in CA1 pyramidal neurons. Cdk5 also has been shown to phosphorylate Munc-18, which interacts with syntaxin 1a and, thereby, modulates the level of vesicle soluble N-ethylmaleimide-sensitive factor attachment protein receptor association with syntaxin 1a in the regulation of exocytosis (26) . It has been shown that LTP is accompanied by the increased phosphorylation of NR2 subunits of NMDARs (51) . The present study provides evidence that Cdk5 can phosphorylate the NR2A subunit of the NMDAR, and that this phosphorylation affects the NMDAregulated synaptic activity. Thus, Cdk5 seems to exert an important role in synaptic transmission.
